Pharmaceutical

Fresenius Kabi and Cellular Origins agree CGT manufacture automation

Fresenius Kabi and Cellular Origins have announced a partnership to advance cell and gene therapy (CGT) by automating manufacturing.

Oct 18, 2024 - 04:00
Fresenius Kabi and Cellular Origins agree CGT manufacture automation
Fresenius Kabi and Cellular Origins have announced a partnership to advance cell and gene therapy (CGT) by automating manufacturing.
Read the original article

Tags:

Previous Article

Bavarian Nordic’s mpox vaccine equally effective in teens as adults

Next Article

Glaukos eyes FDA approval for ocular therapy after Phase III win

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Living kidney donors rely on a promise to protect our future health. We’re scared it will go away

Opinion: Living kidney donors rely on a promise to prot...

Mar 22, 2023

Gail Wilensky on the Geisinger deal, the earnings bonanza, and medical credit cards proliferate

Gail Wilensky on the Geisinger deal, the earnings bonan...

May 9, 2023

Republicans aren’t quite done talking about Obamacare, after all

Republicans aren’t quite done talking about Obamacare, ...

Sep 28, 2023